|
Yes. The LNg IUDs can be used for treatment of women with heavy menstrual bleeding.
|
Lng IUDs decrease the menstrual blood loss (MBL) by about 80% at three months of use and by more than 95% at one year. With correct insertion, the LNg IUD does not cause prolonged or heavy bleeding. However, women should be told that in the first three months of use they may experience many days of spotting and bleeding.
- Luukkainen T, Allonen H, Haukkamaa M, Holma P, Pyorala T, Terho J, et al. Effective contraception with the levonorgestrel-releasing intrauterine device: a 12-month report of a European multicenter study. Contraception 1987;36(2):169-79.
- Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology 1990;97(8):690-4.
- Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology 1991;164(3):879-83.
The LNg IUD has also been used in treatment of menorrhagia. Reduction of MBL gives clients better iron balance and less anemia. The reduced bleeding can also relieve the symptoms of dysmenorrhea.
- Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology 1990;97(8):690-4.
- Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology 1991;164(3):879-83.
- Faundes A, Alvarez F, Brache V, Tejada AS. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation. International Journal of Gynaecology and Obstetrics 1988;26(3):429-33.
|
